ApoB (Apolipoprotein B)
Also called Apolipoprotein B-100
A direct count of atherogenic particles.
- Lab price$20.00
Normal is not optimal
Arguably the most important cardiovascular marker you can run, and newly recommended in the US dyslipidemia guideline.
- Standard
- 49–103 mg/dL
- Optimal
- Same targetscardiovascular disease is the leading cause of death in women and is systematically under-treated.
Standard rangeOptimal
- Standard
- 52–109 mg/dL (population distributionnot a health target)
- Optimal
- <70 mg/dL for primary prevention; <55–65 mg/dL if higher risk. Plaque regression has been observed on coronary CT below 70. Population 'normal' is emphatically not optimal.
Order it yourself
One test, drawn at a Quest lab near you. The price is the lab’s, from Marek’s own menu.
Code CAMERON takes 10% off. Marek’s checkout adds its one-time blood-draw fee to individual tests and shows the total before you pay.
What moves ApoB (Apolipoprotein B)
Genetics (familial hypercholesterolemia), insulin resistance, high saturated fat intake, hypothyroidism, nephrotic syndrome, and — critically for this audience — androgen use, especially oral 17-alpha-alkylated compounds.
If it’s high: Increased atherosclerotic risk that compounds over years.
If it’s low: Favorable.

The free Before‑You‑Stack Lab Kit
The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.
After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.
Everything else about ApoB (Apolipoprotein B)
What can skew the result
3 things can change the reading or the real level
Some change your real level; others only change the reading. Each one says which, and what to do about it.
- Fasting stateTiming
Less affected by eating than a calculated LDL, which is one of its advantages — but it still shifts modestly.
Do this: Fasted is preferable; consistency matters more.
The value is real but reflects a moment — retime it- Acute illnessPhysiological state
ApoB falls during acute illness along with the rest of the lipid panel, so a post-admission draw understates your true particle count.
Do this: Wait six weeks after anything significant.
A real change — retest once it passes- Statins, ezetimibe, PCSK9 inhibitorsDrug or supplement
All lower ApoB, which is the point. The interference is in interpretation — a good ApoB on treatment is not the same as a good untreated one.
Do this: Record what you were taking at each draw.
A real change — account for the cause
Symptoms it helps explain
4 symptoms, and which to test first
Test this first if you have
- Heart disease or stroke runs in my family
Then worth checking for
- High blood pressure
- Chest pain, palpitations or breathlessness
- Memory concerns, or Alzheimer's runs in my family
Plan of attack
What to do, in this order
- Confirm the number is real
Fasting state. Less affected by eating than a calculated LDL, which is one of its advantages — but it still shifts modestly. Fasted is preferable; consistency matters more.
- Read it with its partner
Non-fasting is acceptable for ApoB. It's the marker to watch if you plan to be on hormones for decades. Draw it alongside: Lipoprotein(a) — Lp(a), Lipid Panel (Cholesterol, HDL, LDL, Triglycerides), hs-CRP (High-Sensitivity C-Reactive Protein).
- Work out which direction is yours
If it's high — Increased atherosclerotic risk that compounds over years. Silent until it isn't.
- Fix it in order: food, then cause, then everything else
Nutrition. Reduce saturated fat (the single biggest dietary lever on ApoB), increase soluble fiber (oats, psyllium, beans), add plant sterols, lose visceral fat, and replace saturated with mono/polyunsaturated fats.
Lifestyle. Aerobic exercise, fat loss, smoking cessation, alcohol moderation. - Retest
Every 3–6 months on androgens or after any intervention; annually otherwise. Change one thing at a time, or the retest can't tell you which thing worked.
What ApoB (Apolipoprotein B) measures
And why people check it
What it tells you
A direct count of atherogenic particles. Every LDL, VLDL, IDL and Lp(a) particle carries exactly one ApoB molecule — so ApoB tells you how many plaque-causing particles are circulating, not just how much cholesterol they carry.
Why people check it
Arguably the most important cardiovascular marker you can run, and newly recommended in the US dyslipidemia guideline. It outperforms LDL-C at predicting events — especially in people with metabolic syndrome, diabetes, high triglycerides, or deceptively 'normal' LDL-C.
What ApoB (Apolipoprotein B) means next to other markers
3 patterns worth knowing
- Enhanced athlete — the lipid profile nobody looks at
HDL crashed (<30) · ApoB elevated · Apolipoprotein A-1 low · On orals or high-dose androgens
The single most under-monitored consequence of androgen use. Androgens — especially oral 17-alpha-alkylated compounds — suppress HDL dramatically and raise ApoB. There are no symptoms; the cost is cumulative arterial damage measured in decades.
Prefer injectables over orals and minimize oral duration. Add cardio, soluble fiber, omega-3s. Many long-term users treat ApoB pharmacologically (statin/ezetimibe) with a physician — that's a rational trade if you're committed to being on hormones for years. Track ApoB every 3 months, not just a standard lipid panel.
- The risk your lipid panel cannot see
Lp(a) elevated · ApoB high · Family history of early heart disease · Standard cholesterol "fine"
Lp(a) is almost entirely genetic, largely unmoved by diet, and independently raises cardiovascular and aortic valve risk. A normal LDL alongside it is falsely reassuring.
Measure it once — it barely changes over a lifetime. You cannot lower it much yet, so the response is to drive everything else down hard: ApoB, blood pressure, insulin resistance, smoking. Tell your first-degree relatives to test theirs.
- Cholesterol treated, inflammation ignored
hs-CRP elevated · ApoB at target · Lp-PLA2 or MPO raised
Residual inflammatory risk. Plaque forms and destabilizes through inflammation as well as lipids, so hitting an ApoB target while CRP stays high leaves a meaningful part of the risk untouched.
Rule out the obvious first — CRP rises with any infection, injury or hard training, so retest rested and well. If it stays up: sleep, visceral fat, periodontal disease, gut health, omega-3s. Persistent unexplained elevation deserves a real workup.
Panels that carry ApoB (Apolipoprotein B)
2 panels, prices with code CAMERON
Read it alongside
Related markers, goals and what moves it in the library
Related markers
Goals it helps decide
In the library: what moves it
The deep read, with sources
What the ApoB (Apolipoprotein B) test actually measures, and the references
What ApoB (Apolipoprotein B) actually measures — the analyte, and the assay
The analyte is apolipoprotein B, a 4,536-residue protein of roughly 550 kDa that wraps a lipoprotein particle once and never comes off. One particle, one apoB. That is not a convenient approximation, it is structural — and it is the entire reason this test is different in kind from the cholesterol numbers around it. LDL-C answers how much cholesterol is being carried. ApoB answers how many things are carrying it.
The measurement is an immunoturbidimetric or nephelometric assay: antibody is added, complexes scatter light, and the scatter is compared against an international reference preparation. Two features follow from that and both matter. First, it is a direct measurement — nothing is calculated from anything, unlike the LDL-C beside it. Second, because manufacturers calibrate to a common reference material, apoB transfers between laboratories better than almost any other lipid number on the panel.
It also does not need a fast. The joint European Atherosclerosis Society and European Federation of Clinical Chemistry consensus concluded that fasting is not routinely required for a lipid profile Nordestgaard 2016, and apoB is the member of the panel least disturbed by a recent meal, because eating adds cholesterol and triglyceride to particles without much changing how many particles there are.
What the assay counts, precisely: every LDL, VLDL, IDL and Lp(a) particle in the tube, each contributing exactly one molecule. In the fasting state that is about 90% LDL. It is a sum, and one of the limits further down this page follows from that.
ApoB (Apolipoprotein B): what changes the blood, and what only changes the reading
What changes the particle count in your blood — ranked:
- Genetics. Familial hypercholesterolemia and the common polygenic score both act on LDL receptor traffic, which sets how fast particles are removed. This is the largest single determinant in most people and it is present from birth.
- Lipid-lowering drugs. Statins, ezetimibe, bempedoic acid and PCSK9 inhibitors all work by increasing hepatic LDL receptor activity or reducing production, and they move apoB more reliably than anything else available.
- Insulin resistance and visceral fat. These raise VLDL particle secretion, which is why apoB and LDL-C separate most in exactly the metabolic phenotype where LDL-C looks reassuring Sniderman 2024.
- Dietary saturated fat, through the same receptor pathway.
- Hypothyroidism, which slows LDL receptor-mediated clearance and raises apoB — one of the few places where two panels on this site share a mechanism rather than a page.
- Androgens, particularly oral 17-alpha-alkylated compounds, which raise apoB while suppressing HDL.
- Nephrotic syndrome, cholestasis and pregnancy, each by a different route.
What changes only the reading — a short list, and that is the point of the marker:
- Severe lipemia. A turbidimetric assay measures scattered light, so a grossly turbid specimen can distort it; this is the same specimen problem that gets samples rejected outright at extreme triglyceride concentrations Van Elslande 2021.
- Paraproteins, which precipitate in some turbidimetric systems.
- An acute-phase state. Cholesterol and apoB fall for weeks after a myocardial infarction, major surgery or serious infection, so a value drawn in hospital understates the patient's usual concentration.
- Nothing much else. There is no biotin problem, no heterophile problem and no calculation to go wrong — which is precisely the argument for preferring it to an estimated LDL-C Sajja 2021.
Reference interval or decision threshold — which kind of number ApoB (Apolipoprotein B) is
Two different kinds of number get printed in the same box, and confusing them is the mistake this page exists to prevent.
The reference interval — the 52–109 mg/dL kind of figure — is the central 95% of whoever that laboratory measured. In a population where atherosclerosis is the leading cause of death, that interval describes what is common. It is not a claim that anything inside it is safe, and it is the only sense in which a population apoB is 'normal'.
The decision thresholds — the sub-70 and sub-65 kind of figure — are a different species entirely: they come from event rates in cohorts and from the trial evidence that lowering apoB lowers those rates. In 293,876 UK Biobank adults aged 40 to 73 followed to 19,982 new-onset atherosclerotic events, the analysis that matters was of discordance: what happens to risk when apoB and the cholesterol measures disagree Sniderman 2024. The same cohort has been used to show apoB outperforming even a direct LDL particle count Epstein 2025, and comparisons of apoB with LDL-C and non-HDL-C as risk markers keep landing in the same place Sehayek 2025.
So: the reference interval is distributional, the target is outcome-derived, and they disagree by a wide margin. A 105 mg/dL apoB is inside the reference interval and above every primary-prevention target published. Both statements are true and only one of them is about you. The same logic is now being extended past coronary disease — apoB and Lp(a) have been assessed for sex-specific aortic stenosis risk in the same biobank Shi 2026.
How you would know your ApoB (Apolipoprotein B) was wrong — and when to redraw
Six to eight weeks after any change, and the number comes from particle kinetics. An LDL particle's residence time in plasma is measured in days, so the pool reaches a new steady state within a few weeks of a change in production or clearance. Redraw at two weeks after starting a statin and you will see most of the effect; redraw at eight and you will see all of it, on a stable baseline.
Conditions that must match: the same laboratory; at least four to six weeks clear of any acute illness, injury or surgery; a stable weight, since an active deficit moves lipids independently of the intervention; and honesty about adherence, which is by far the commonest reason an apoB has not moved.
What would have to change for the retest to mean something. ApoB should move with non-HDL cholesterol. When the two travel together, the change is real; when they separate, that separation is itself the finding and it usually means the particles have changed composition — smaller, more cholesterol-depleted particles give a higher apoB for the same cholesterol Sniderman 2024. ApoB falling while non-HDL-C is flat, or the reverse, is the one pattern that should send you back to the laboratory rather than to a conclusion.
How you would know the value was wrong. A grossly discrepant apoB with an unremarkable full lipid panel, in a specimen described as lipemic, should be repeated on a properly fasted sample Van Elslande 2021. And a persistently high apoB with a normal-looking LDL-C is not evidence of an error — it is the single most useful result this test produces, and the confirmatory step is Lp(a), not a repeat.
What ApoB (Apolipoprotein B) cannot tell you
It cannot tell you what kind of particle you have too many of. The count sums LDL, VLDL, IDL and Lp(a). Two people with an apoB of 110 mg/dL can have completely different panels underneath it, and the clinical response differs.
It hides a high Lp(a). Every Lp(a) particle carries an apoB and is counted here, and Lp(a)-cholesterol has been shown to make up anywhere from 5.8% to 57.3% of what a laboratory reports as LDL cholesterol in people who have it Yeang 2021. ApoB does not flag which of its particles are the genetically determined, diet-resistant kind. That takes a separate test, once.
It measures exposure, not disease. ApoB describes how many atherogenic particles are circulating; it says nothing about how much plaque is already in an artery wall, which is a question for imaging. A low apoB at 55 does not mean clean arteries and a high one at 35 does not mean disease.
It cannot be read from a single draw in an acutely ill person, for the acute-phase reason above.
The wrong inference readers actually draw is the reverse of the usual one: a normal LDL-C alongside a high apoB is not normal risk. That combination — discordance — is common, it is concentrated in people with insulin resistance or high triglycerides, and it is the situation in which the cholesterol number systematically understates the particle burden Sniderman 2024. It is also the situation in which a calculated LDL-C is least reliable in the first place Sajja 2021.
Sources read for these sections
- Sniderman AD, et al. Discordance among apoB, non-high-density lipoprotein cholesterol, and triglycerides: implications for cardiovascular prevention. European Heart Journal 2024 · PMID 38700053
- Epstein E, et al. Apolipoprotein B outperforms low density lipoprotein particle number as a marker of cardiovascular risk in the UK Biobank. European Journal of Preventive Cardiology 2025 · PMID 40887080
- Sehayek D, et al. ApoB, LDL-C, and non-HDL-C as markers of cardiovascular risk. Journal of Clinical Lipidology 2025 · PMID 40681368
- Nordestgaard BG, et al. Fasting is not routinely required for determination of a lipid profile. European Heart Journal 2016 · PMID 27122601
- Sajja A, et al. Comparison of Methods to Estimate Low-Density Lipoprotein Cholesterol in Patients With High Triglyceride Levels. JAMA Network Open 2021 · PMID 34709388
- Yeang C, et al. Novel method for quantification of lipoprotein(a)-cholesterol: implications for improving accuracy of LDL-C measurements. Journal of Lipid Research 2021 · PMID 33636163
- Shi W, et al. Moving beyond Low-Density Lipoprotein cholesterol: apolipoprotein B and Lipoprotein (a) for sex-specific risk assessment of aortic stenosis in the UK Biobank. European Journal of Preventive Cardiology 2026 · PMID 42104638
ApoB (Apolipoprotein B) questions
6 answered
- What is a normal ApoB (Apolipoprotein B) level?
- Women: 49–103 mg/dL. Men: 52–109 mg/dL (population distribution — not a health target). Ranges vary by laboratory and assay; always compare to the range printed on your own report.
- What is the optimal ApoB (Apolipoprotein B) level?
- Women: Same targets — cardiovascular disease is the leading cause of death in women and is systematically under-treated. Men: <70 mg/dL for primary prevention; <55–65 mg/dL if higher risk. Plaque regression has been observed on coronary CT below 70. Population 'normal' is emphatically not optimal.
- What does a high ApoB (Apolipoprotein B) mean?
- Increased atherosclerotic risk that compounds over years. Silent until it isn't.
- What does a low ApoB (Apolipoprotein B) mean?
- Favorable. Very low values are usually genetic and generally benign.
- How often should I retest ApoB (Apolipoprotein B)?
- Every 3–6 months on androgens or after any intervention; annually otherwise.
- How do I test ApoB (Apolipoprotein B)?
- Through Marek Diagnostics without a doctor's visit, drawn at a Quest Diagnostics location in the US. Code CAMERON applies 10% off automatically through the links on this page.
Sources: 2026 AHA/ACC Guideline on the Management of Dyslipidemia — ApoB introduced as recommended measurement. Sniderman AD et al., JAMA Cardiol 2019 — ApoB vs LDL-C discordance.
Turn your ApoB (Apolipoprotein B) number into a plan
This page tells you what the number means and the order to act in. Skool is where it becomes a plan for your situation, read against your own labs.
- Supplement form, timing and how long to run it
- The hormones and compounds that move it, and what to watch
- Your retest calendar: what to draw, when, and what a change means
5.0 (15 reviews)1,500+ members

Want it built around you?
Educational and research purposes only. Not medical advice; talk to your clinician about results. Lab ranges vary by assay and laboratory: compare against the range printed on your own report. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer and affiliate disclosure